ODDITY Q2 EBITDA Turns Positive but Revenue Still Down 25%; Cash Burn Continues

What happened

ODDITY Tech reported Q2 2026 net revenue of $181 million, a 25% year-over-year decline that landed at the better end of its guided range of -25% to -30%. Adjusted EBITDA of $13 million reversed the Q1 loss of -$7 million and beat guidance of $8-10 million, suggesting improved cost discipline or early stabilization in customer acquisition costs. However, the company's cash and investments fell from $667 million at end Q1 to $561 million, a $106 million decline in one quarter, likely driven by continued share buybacks and negative free cash flow. Management expects sequential revenue improvement in Q3, indicating the worst declines may be passing, but the press release omits details on CPA and first-order trends, the critical metrics for thesis validation. Net income of $13 million and adjusted net income of $11 million show modest profitability, but the gap suggests some non-recurring items; overall, the results are mildly encouraging but not conclusive evidence of a durable recovery.

Implication

The Q2 EBITDA beat and guidance for sequential revenue improvement reduce near-term downside risk, but the stock remains a WAIT because customer acquisition cost normalization is unverified in the press release. The $106 million cash decline in one quarter is a red flag that buybacks may be consuming liquidity faster than the operating recovery can generate cash, potentially diminishing the balance sheet buffer that underpins the margin of safety. If Q3 revenue improves sequentially and CPA continues to trend down, the base case of $18 per share becomes more probable, but if cash burn persists or management fails to provide explicit CPA updates, the bear case of $11 regains credibility. At the current price around $16.55, the risk-reward is balanced but not compelling; an entry below $14 would offer a better margin of safety, while a break above $24 would signal that the market is pricing in a full recovery before evidence is conclusive. Therefore, investors should hold existing positions and avoid adding unless either the price drops below $14 or Q3 results show a clear inflection in customer acquisition economics.

Thesis delta

The original thesis required proof within 6 months that CAC normalization is real and first-order volumes are rebuilding; Q2 results provide partial evidence on the EBITDA front but fail to directly address CPA or first-order trends. The shift is modestly positive because the company returned to positive EBITDA and guided for sequential revenue improvement, but the thesis remains unproven due to the lack of disclosure on acquisition metrics and the concerning cash burn. The WAIT rating and scenario probabilities (45% base, 30% bear, 25% bull) remain unchanged until Q3 data provides clearer confirmation.